Table 3 The comparison between the clinical effectiveness of the hAM group and the SSDZ group
Items assessed | Day | hAM group | SSDZ group | P-VALUE | ||||
|---|---|---|---|---|---|---|---|---|
N(%)_ | Presented | Not presented | N(%) | Presented | Not presented | |||
Wound epithelialization and granulation | 7 | 25(100%) | 23(96%) | 2(4%) | 25(100%) | 10(40%) | 15(60%) | < 0.001 Chi square |
14 | 23(100%) | 23(100%) | 0(0%) | 22(100%) | 14(60%) | 8(40%) | = 0.001 Fisher exact test | |
30 | 23(100%) | 23(100%) | 0(0%) | 22(100%) | 22(100%) | 0(0%) | = 0.1 Fisher exact test | |
Scar on day 30 | Scar-free | 8(32%) | - | - | 1(4%) | - | - | < 0.001 Fisher exact test |
Mild scar | 13(52%) | - | - | 3(12%) | - | - | ||
Moderate scar | 4(16%) | - | - | 16(64%) | - | - | ||
Sever scar | 0(0%) | - | - | 5(20%) | - | - | ||
Pain severity | The entire period | Median | M | SD | Median | M | SD | < 0.001 t test |
4 | 3.56 | 1.15 | 5 | 5.4 | 1.44 | |||
Dressing renewal frequency | The entire period | 1 | 1 | 0.001 | 12 | 3.44 | 5.67 | < 0.001 t test |
Painkiller consumption | The entire period per person | Median | M | SD | Median | M | SD | < 0.001 |
50 | 72Â mg | 29.15 | 700Â mg | 806Â mg | 49.3 | |||
Number of hospital stay | The entire period | 3 | 3.36 | 0.952 | 10 | 11.84 | 5.13 | < 0.001 t test |
Costs per person | The entire period | 7,100,000(IRR*) 170$ | 7,214,000* 172$ | 2078988.13* 49$ | 2,970,000* 71$ | 3,216,800* 77$ | 1408506.60* 36$ | < 0.001 t test |